About Cencora, Inc. (COR)
Cencora, Inc. is a Medical Distribution company operating in the Healthcare sector. The company is headquartered in Conshohocken, United States. COR has been publicly traded since 1995, giving it 31+ years of trading history.
Cencora, Inc. (COR) has been publicly traded since 1995, making it a 31-year-old public company. It operates in the Medical Distribution industry within the Healthcare sector. The company is headquartered in Conshohocken, United States and employs approximately 47,000 people. With a market capitalization of $68 billion, COR is a large established company.
COR trades on the US stock exchanges (NYSE/NASDAQ) and is classified as a large-cap-cap stock with a market capitalization of approximately $68 billion. The company employs approximately 47,000 people worldwide.
Key Statistics
- Current Price
- $349.95
- Market Cap
- $68.08B
- 52-Week High
- $377.54
- 52-Week Low
- $255.76
- Sector
- Healthcare
- Industry
- Medical Distribution
COR Investment Performance
COR has gained 3.8% year-to-date in 2026. Over the past 5 years, a $1,000 investment in COR would have grown to $3,498, representing a 249.8% total return. Since its IPO in 1995, a $1,000 investment would now be worth $184,810.
$1,000 Invested in Cencora, Inc. (COR)
How much would $1,000 invested in COR be worth today?
What would $1,000 invested in COR 1 year ago be worth today?
A $1,000 investment in Cencora, Inc. (COR) in 2025 would be worth $1,377 as of May 2026, representing a +37.7% total return.
What would $1,000 invested in COR 3 years ago be worth today?
A $1,000 investment in Cencora, Inc. (COR) in 2023 would be worth $2,395 as of May 2026, representing a +139.5% total return.
What would $1,000 invested in COR 5 years ago be worth today?
A $1,000 investment in Cencora, Inc. (COR) in 2021 would be worth $3,498 as of May 2026, representing a +249.8% total return.
What would $1,000 invested in COR 10 years ago be worth today?
A $1,000 investment in Cencora, Inc. (COR) in 2016 would be worth $5,340 as of May 2026, representing a +434.0% total return.
What would $1,000 invested in COR at IPO be worth today?
A $1,000 investment in Cencora, Inc. (COR) at IPO would be worth $184,810 as of May 2026, representing a +18381.0% total return.
Monthly Returns Heatmap
Over the past 30+ years (371 months), Cencora, Inc. (COR) has averaged a monthly return of +1.79% with a median return of +1.96%. The stock had 227 positive months (61%) and 144 negative months (39%). The best month in COR's history was September 2000 with a +33.8% return, while the worst was August 1998 at -38.2%. Historically, January tends to be the strongest month (averaging +4.6%), and August the weakest (-0.7%).
COR's longest winning streak was 11 consecutive months of gains, while its longest losing streak was 5 consecutive months of losses. The best full year was 2000 with a cumulative return of +140.5%, and the worst was 1999 at -56.5%.
Annual Returns
Over 31 years of trading history, Cencora, Inc. (COR) has delivered an average annual return of +23.17% with a median return of +19.51%. The compound annual growth rate (CAGR) is +17.08%. The stock posted gains in 26 years (84%) and losses in 5 years (16%).
COR's best year was 2000 with a +232.51% gain, while the worst was 1999 at -53.27%. The longest streak of consecutive positive years was 8, and the longest losing streak was 1 years. COR achieved double-digit gains (10%+) in 21 years. It suffered double-digit losses in 5 years.
| Year | Return | Start | End |
|---|---|---|---|
| 2026 | +3.79% | $337.17 | $349.95 |
| 2025 | +51.48% | $222.58 | $337.17 |
| 2024 | +10.37% | $201.67 | $222.58 |
| 2023 | +25.33% | $160.91 | $201.67 |
| 2022 | +26.26% | $127.44 | $160.91 |
| 2021 | +44.09% | $88.45 | $127.44 |
| 2020 | +23.37% | $71.69 | $88.45 |
| 2019 | +23.51% | $58.04 | $71.69 |
| 2018 | -17.57% | $70.42 | $58.04 |
| 2017 | +19.51% | $58.92 | $70.42 |
| 2016 | -23.32% | $76.84 | $58.92 |
| 2015 | +16.39% | $66.02 | $76.84 |
| 2014 | +29.95% | $50.80 | $66.02 |
| 2013 | +65.35% | $30.72 | $50.80 |
| 2012 | +17.95% | $26.05 | $30.72 |
| 2011 | +10.30% | $23.62 | $26.05 |
| 2010 | +32.39% | $17.84 | $23.62 |
| 2009 | +47.93% | $12.06 | $17.84 |
| 2008 | -19.84% | $15.04 | $12.06 |
| 2007 | +3.34% | $14.56 | $15.04 |
| 2006 | +8.90% | $13.37 | $14.56 |
| 2005 | +41.35% | $9.46 | $13.37 |
| 2004 | +2.54% | $9.22 | $9.46 |
| 2003 | +5.74% | $8.72 | $9.22 |
| 2002 | -14.42% | $10.19 | $8.72 |
| 2001 | +25.90% | $8.10 | $10.19 |
| 2000 | +232.51% | $2.43 | $8.10 |
| 1999 | -53.27% | $5.21 | $2.43 |
| 1998 | +11.59% | $4.67 | $5.21 |
| 1997 | +20.73% | $3.87 | $4.67 |
| 1996 | +46.21% | $2.64 | $3.87 |
COR Investment Analysis: Valuation, Risk & Dividends
Key factors to consider when evaluating Cencora, Inc. as an investment
Valuation
COR currently trades at a trailing P/E ratio of 42.0, which is considered high relative to the broader market. The forward P/E of 17.8 suggests analysts expect earnings to be lower in the coming year. The price-to-book ratio stands at 35.7. The price-to-sales ratio is 0.2.
Dividends
Cencora, Inc. pays a dividend to shareholders with a current yield of 0.69%. This translates to $2.40 per share annually. The payout ratio of 27% indicates sustainable dividend coverage.
Risk & Volatility
COR has a beta of 0.65, indicating it is less volatile than the overall market. The stock's 52-week range is $255.76 to $377.54, and it currently trades in the upper half of its 52-week range.
Analyst Ratings
Based on 13 analyst opinions, COR has a consensus "buy" rating. The average price target of $410.00 suggests 17.2% upside from current levels.
Frequently Asked Questions: COR
What sector is COR in? ▼
COR operates in the Healthcare sector, specifically in the Medical Distribution industry. This sector includes pharmaceutical companies, biotechnology firms, medical device manufacturers, and healthcare providers.
How has COR performed historically? ▼
Over 31 years of trading history, COR has posted gains in 26 years (84% of the time). The best year was 2000 with a +232.5% return. Past performance does not guarantee future results.
How can I invest in COR? ▼
You can invest in COR through any brokerage account that offers access to US stock exchanges. Popular options include commission-free brokers like Fidelity, Charles Schwab, or Robinhood (US), or international brokers like Interactive Brokers. You can buy individual shares or invest through ETFs that hold COR.
Does COR pay dividends? ▼
Cencora, Inc. pays a dividend to shareholders with a current yield of 0.69%. This translates to $2.40 per share annually. The payout ratio of 27% indicates sustainable dividend coverage.
What does Cencora, Inc. do? ▼
Cencora, Inc. is a Medical Distribution company operating in the Healthcare sector. The company is headquartered in Conshohocken, United States.
What sector is COR in? ▼
COR operates in the Healthcare sector, specifically in the Medical Distribution industry.
When did COR go public? ▼
Cencora, Inc. went public in 1995, making it a 31-year-old public company as of 2026.
How much would $1,000 invested in COR 5 years ago be worth today? ▼
A $1,000 investment in COR five years ago would be worth approximately $3,498 today, representing a 249.8% return.
How much would $1,000 invested in COR 10 years ago be worth today? ▼
A $1,000 investment in COR ten years ago would be worth approximately $5,340 today, representing a 434.0% total return over the decade.
What is COR's 3-year return? ▼
Over the past 3 years, COR has returned 139.5%. A $1,000 investment would have grown to $2,395.
How much would $1,000 invested in COR at IPO be worth today? ▼
If you invested $1,000 in COR at its IPO in 1995, it would be worth approximately $184,810 today, a 18,381.0% return over 31 years.
Does COR pay dividends? ▼
Yes, Cencora, Inc. pays a dividend with a current yield of 0.69%, which is $2.4 per share annually.
What is COR's market cap? ▼
Cencora, Inc. has a market capitalization of $68 billion, classifying it as a large-cap company.
What is COR's P/E ratio? ▼
COR has a trailing P/E ratio of 42.0 and a forward P/E of 17.8, which measures how much investors are paying per dollar of earnings.
Is COR a buy, hold, or sell? ▼
Based on 13 opinions, COR has a consensus "buy" rating. The average price target is $410.0.
Last updated: 3/14/2026